Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Bictegravir/Emtricitabine/Tenofovir alafenamide

Thursday 15 February 2018

Interactions with bictegravir/emtricitabine/tenofovir alafenamide are now included on the website, HIV i Chart app and printable charts. For ease of viewing on small screens, the listing appears as “Bictegravir/FTC/TAF”.

Bictegravir/emtricitabine/tenofovir alafenamide (Bictarvy®) is a fixed dose combination and is indicated as a complete regimen for the treatment of HIV-1 infection. It was recently approved by the FDA and is under evaluation by the European Medicines Agency (EMA).

Sponsor logo gilead Sponsor logo viiv Thera logo Frontier logo
Hiv dt glas 2020 cmyk logo Eacs logo 2014 Bhiva 2018 Basel text
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017
building_better_healthcare_awards_2016 healthline-best-HIV-and-AIDS-apps-of-2016